On March 26, 2018 Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, reported that it will release its financial results for the fourth quarter and full year ended December 31, 2017 on Monday, April 2, 2018 (Press release, Cancer Genetics, MAR 26, 2018, View Source [SID1234524985]). The Company will hold a conference call at 4:30 PM Eastern on Monday, April 2, 2018 to discuss the financial results and provide an update on its strategic direction and key organizational improvements being made by the Company.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CONFERENCE CALL & WEBCAST
Monday, April 2, 2018, 4:30 p.m. Eastern Time
Domestic: 888-394-8218
International: 323-701-0225
Conference ID: 7874980
Webcast: View Source
Replay – Available through April 16, 2018
Domestic: 844-512-2921
International: 412-317-6671
Conference ID: 7874980